Schedule an Appointment

Marketplace

Please Read Our Disclaimer

The investment opportunities below are not an offer to the general public to purchase any form of securities. Every investment opportunity below should be considered to be a very high risk investment and the investor must be comfortable in accepting and bearing the very high level of risk associated with any of the investment opportunities listed on this site. The information contained in these investment opportunities is proprietary and strictly confidential. It is intended to be reviewed only by accredited investors in order to evaluate the investment opportunities and should not be used for any other reason or made available to any other person or entity without the prior written consent of The OCMX (P2P Financial Inc.). The technology and process used on this website is protected by existing or pending patents owned by The OCMX. Nothing on this site including any related communication is intended to provide specific financial, investment, tax, legal, accounting or other advice to you, and should not be acted or relied upon in that regard without seeking the advice of a professional. In all circumstances, you should seek guidance from your current advisor as your advisor can help to ensure that your own circumstances have been properly considered and any action is taken on the latest available information.
logo-sg
Book a Conference Call
Get More Information

[frm-field-value field_id=418  entry_id=73767]

 

Location: [frm-field-value field_id=383 entry_id=73767], [frm-field-value field_id=382 entry_id=73767]

Sector: [frm-field-value field_id=381 entry_id=73767]

 

Add to Shortlist
Express Interest

Cryogenic storage of blood products or “Immune Cell Banking”. Healthy immune cells can be isolated from blood and indefinitely cryopreserved for potential use in personalized immune therapies to combat cancers and other immune and age related diseases.

Business Documents

MG cp Summary
  • First Market MoverThere are currently no other companies in North America offering this new product.
  • Unmet medical need – There is no other source for individuals of personalized, diverse, healthy and unimpaired mature immune cells.
  • Experienced management team – The core management team brings together the cell banking expertise & experience, scientific know-how and marketing and financial leadership to rapidly execute on Proactive’s business plan
  • Protocols for processing and storing immune cells and information management – Proactive will be developing its own processes for separating, freezing and storing immune cells using established protocols that have been proven to be safe.
  • Accessibility and ease of doing business – Customers can complete their transaction on-line, with telephone support if necessary.
  • Pricing – Prices have been set to be attractive to the target audience and competitive with other forms of cellular banking services.

Cryogenic storage of blood products or “Immune Cell Banking”. Healthy immune cells can be isolated from blood and indefinitely cryopreserved for potential use in personalized immune therapies to combat cancers and other immune and age related diseases.

Jeff Schulz, President & CEO Mr. Schulz is a senior executive and marketing professional with over 30 years of experience. During his career, Jeff has worked on some of the most well-known brands in BC and the country. Jeff moved to BC in 1991 and was actively involved for many years with BC’s Children’s Hospital; where he created and launched Jeans Day. He was Chair of the Board of Governors at the Vancouver Playhouse Theatre Company and was on the Board of Governors for the Vancouver International Wine Festival for nine years.

Jeff Charpentier, Chief Financial Officer Jeff Charpentier is a senior financial executive with a successful record of leadership, management and business accomplishments in all areas of financial management gained in a variety of businesses, primarily in high growth technology sectors. He brings experience in working with entrepreneurial oriented companies at various stages of product development through to commercialization.

Robert Holt, Ph.D., Chief Scientific Officer Dr. Holt is currently the Head of Sequencing, Michael Smith Genome Sciences Centre, BC Cancer Agency and Professor, Molecular Biology & Biochemistry, Simon Fraser University and Professor, Department of Medical Genetics, University of British Columbia.

Ernest Stacey, Director of Operations Ernest Stacey is an experienced Laboratory and Corporate Director. For over 40 years he has been involved with a number of clinical laboratories and services in the capacities of teaching, management and quality assurance, specifically in the field of Hematology. With a career that has taken Ernest to the leading edge of health sciences at various facilities across Canada, he has earned the respect of his peers and subordinates as a person of integrity and honesty.